A novel antihypertensive effect of exenatide, a GLP-1 agonist.
Dandona
Paresh
P
Division of Endocrinology, State University of New York at Buffalo, Buffalo, New York, USA. pdandona@KaleidaHealth.org
Chaudhuri
Ajay
A
Dhindsa
Sandip
S
D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000819:agonists*; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D010455:Peptides / Q000494:pharmacology* / Q000627:therapeutic use; D014664:Vasodilation; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014688:Venoms / Q000494:pharmacology* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D010455:Peptides; D014665:Vasodilator Agents; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide